Select the best companies
Find the right moment to invest in and to divest of healthcare companies
As a healthcare investor, independently from your investment profile (as a business angel, venture capital, equity funding, family offices or even through an M&A process), you need to make sure that:
- You select the best projects to allocate your money to
- Your investments are moving in the right direction
- You chose the right moment to divest
Most likely you see dozens of investment opportunities each week, listen to many entrepreneurs who are proud of their inventions and solutions, participate in a good number of boards listening to all kinds of reasons for delayed justifications, or even look for the right moment to disinvest. You may be asking yourself, among other questions:
A. In the case of a new investment:
- Does this product I have been offered solve a real problem? Does the company offering the product have the right team? What is the business model that supports this brilliant idea?
- Am I certain that the product will be accepted by the hypothetical customers they expect to target (patients, physicians or healthcare providers among others)? Are they sure that those customers are willing to use, and more importantly, to pay for that product? Who are the real payers?
- Does the business model create and deliver enough value to capture what we need to make it profitable and attractive for future partners and investors?
- Am I sure I am investing in the right projects?
B. In the case of investments you have already made:
- Are we certain that we have the best business model? Do we even understand our business model?
- Are we performing all of the business development activities in parallel with the product development activities?
- Have we validated the hypotheses along with our business model?
Are we sure that the product will be accepted by the hypothetical customers we expect to target (patients, physicians or healthcare providers among others)? Are we sure that those customers are willing to use, and more importantly, to pay for that product? Who are the real payers?
- Are we targeting to commercialise internally or transfer the project at the proof of concept stage? In that case, do we know what the potential partners are expecting to see from us in order to acquire our company or our rights? Do we know who they are? Have we spoken to them?
C. In the case of divestment:
- When is the right moment to divest in order to get maximum return within my expected timeframe?
- How do I find the best investor to acquire my shares on such a large global marketplace? What is the best strategy to approach them?
- How should I validate their interest in our product?
- How do I communicate with my company team as well as with our potential investors to make sure that we all speak the same language? How can I manage such a complex multicultural, multidepartmental, multidisciplinary project?
- How can I align my team’s understanding and needs while also including those of the external parties?
- How should I negotiate with the external parties? Should I propose terms or should I expect them to bring their terms to the table?
At trifermedCBDO we have the methodology, the competence and the expertise to help you manage this fascinating process. From business model design (or a review of an existing one) to guiding you through the requested validation, working together as a team, we will support you throughout the journey to make sure that you invest in the companies that add real value to the market. During this process we will be continuously providing feedback from the selected markets and we will learn together from them, market by market.
The outcome of this process will help you make the right decisions:
- As an investor in new companies, if the feedback from the process is positive and the hypotheses are validated, you may decide to invest in them. If the feedback from the process is negative and the hypotheses are not validated, you may decide not to invest in them and/or suggest alternative strategies to improve their business model.
- When working with your invested companies, if the feedback from the process is positive and the hypotheses are validated, you may decide to arrive at valuable partnerships with other companies to move everyone along the value chain. If the feedback from the process is negative and the hypotheses are not validated, you may decide to pivot to a better business model or simply divest.
- When divestment is your plan, if the feedback from the process is positive and the hypotheses are validated, you may decide to sell your shares. If the feedback from the process is negative and the hypotheses are not validated, you may decide to wait for a better moment to divest or to reduce the expectations on your ROI.
In any of the above scenarios, the feedback from the market will help you make the right decisions. The trifermedCBDO team will also support you, on demand, during the negotiation process bringing together our expertise from more than 130 successfully signed deals.
Please do not hesitate to contact us by phone or directly sending an email to any of our team members. We will be pleased to provide any additional information you may need. We look forward to hearing from you and having the opportunity to provide you with state-of-the-art business development services.